**Directions: Read the given passage carefully to answer the following questions.
Each question will have five alternatives as its answer. Choose the correct option as your answer.**
Dr. Patel: The COVID-19 pandemic illuminated the glaring inequalities entrenched in global public health systems. It acted as a stark reminder of the pressing need to reassess and fortify our global health infrastructure. One of the pivotal elements among various strategies being endorsed by policymakers worldwide is the enhancement of our global health architecture. This, undoubtedly, serves as a catalyst not just for economic growth but also for safeguarding the planet's future. As we delve into these crucial strategies, I can't help but emphasize the significance of prioritizing access to blood and its products in the quest to construct a resilient global health framework.
Dr. Khan: I couldn't agree more, Dr. Patel. The role of blood and its myriad products across a spectrum of medical contexts cannot be overstated. From scheduled surgeries to emergency interventions, and the treatment of conditions like cancer, thalassemia, and postpartum hemorrhage, their irreplaceable significance in upholding patient health is undeniable. Yet, a recent World Health Organization report brought into focus the profound global disparities in blood collection. It's astounding how regions like the WHO African region, housing 14% of the global population, only manage to collect 5% of global donations. Comparable patterns emerged in low-income and lower-middle-income nations, underscoring the need for concerted efforts to bridge this stark gap in access to vital medical resources.
Dr. Patel: Indeed, Dr. Khan. Even countries like India, despite improvements in their blood management systems, grapple with persistent shortages. Consider this, according to WHO standards for self-sufficiency, India collected approximately 1.27 crore blood units in 2019-20 but faced a shortage of over six lakh units. The repercussions of such shortages are substantial, impacting not just critical healthcare services but also endangering lives. Take, for instance, the implications for accident victims - a shortage significant enough to put approximately 12,000 lives at risk. This deficit also jeopardizes around 1,00,000 heart surgeries and nearly 30,000 bone marrow transplants. It's a systemic issue that requires urgent attention and action.
Dr. Khan: Absolutely, Dr. Patel. One crucial avenue to address these inequities lies in establishing robust public-private partnerships (PPPs). Collaborations between leading industry players harbour immense potential in devising innovative models for blood collection and distribution. The hub and spoke model, for instance, stands out as a promising solution. Especially in resource-constrained settings within Low- and Middle-Income Countries (LMIC), this model can effectively bridge critical gaps in blood availability and distribution, thereby bolstering accessibility and availability of blood and its derivatives. Furthermore, optimizing the utilization of blood and its products becomes more feasible through such innovative approaches, minimizing losses due to expiration and ensuring maximal utilization.
Dr. Patel: True, Dr. Khan. It's disheartening to note that over three years, from 2014-15 to 2016-17, a surplus of 30 lakh blood units and related products were discarded in our country due to various reasons, including expiration and storage-related degradation. Implementing models like the hub and spoke can revolutionize blood distribution, ensuring safer and more efficient utilization, particularly in community health centres and smaller hospitals, even in geographically challenging terrains. However, beyond logistics, another substantial challenge revolves around dispelling myths and misconceptions about voluntary blood donation. Targeted awareness campaigns, driven by both government and private sectors, leveraging platforms like social media and innovative tools, could play a pivotal role in reshaping perceptions and encouraging voluntary donations.
Dr. Khan: Absolutely, Dr. Patel. As we navigate beyond the shadows of the COVID-19 pandemic and chart a course for a more equitable and sustainable future, the spotlight must remain on fortifying our health systems. Blood and its products are foundational to modern medicine, and strengthening the blood management ecosystem should remain a priority for policymakers and leaders worldwide. It's not merely about policy changes; it's about instigating a cultural shift towards voluntary donation and ensuring seamless access to these life-saving resources. A collective effort involving government, industry, and society at large is essential to sculpt a more resilient and inclusive global health architecture.